The product carbon footprint of Evonik’s DL-methionine from Singapore has been reduced by 6%.
The initiative heralds a new chapter in the long-running partnership between Lallemand Animal Nutrition and the University of Plymouth.
Martine Boon has been appointed as the new managing director of GMP+ International.
U.S. Soy Sustainability Assurance Protocol now includes carbon footprint analysis for Scope 3 reporting.
The company is spearheading an initiative that unites universities and enterprises to form an innovative consortium dedicated to advancing synthetic biology technology.
Allozymes and Adisseo partnership will start by developing a novel environmentally friendly process for methionine.
Aker BioMarine is spotlighting two recently published scientific studies that highlight how innovative approaches can yield greater efficiency and less impact for the industry while improving performance results.
In addition to Deep Branch’s IP portfolio, Aerbio has acquired piloting facilities at the Brightlands Chemelot Campus in Limburg, the Netherlands.
Erik Tveteraas joins NoMy from Nutreco, where he was the head of Nutreco’s corporate venture capital arm NuFrontiers and oversaw a multi-million dollar portfolio.
The company has declared Force Majeure on deliveries of selected vitamins A and E and carotenoids.
After a European Commission’s investigation and the acceptance of the proposed remedies by the companies, the commission said the transaction would not raise competition concerns.
The center is designed as a research and demonstration center and also aims to support investors in evaluating the economic viability of larger plants.
Nufarm will pay up to USD 5 million in consideration for the license.
The protein derived from methanotrophic bacteria achieved GRAS status for use in crustacean feed in the U.S.
ImagoAI is collaborating with the United States Department of Agriculture (USDA) to develop a handheld mycotoxins test making mycotoxin testing accessible anywhere.
The acquisition ushers in a new future for the production of amino acids in France and in Europe, reinforcing sovereignty in the animal sector.
The company plans to utilize an asset-light strategy encompassing licensing and strategic partnerships.
Investors participating in the round include the Yield Lab Asia Pacific, SEEDS Capital, Future Planet Capital, Conservation International Ventures and SeaAhead Blue Angels.
Caitlin Wege, who recently joined the company, is the new CEO.
With this expansion, Nesle becomes the largest insect production site in the world.
